
|Videos|July 31, 2020
Targeted Therapy in Early-Stage HER2+ Breast Cancer
Author(s)Targeted Oncology
Experts from Sarah Cannon Research Institute talk about the expanding role of targeted treatment options in early HER2+ breast cancer.
Experts from Sarah Cannon Research Institute talk about the expanding role of targeted treatment options in early HER2+ breast cancer.